US 10010612
Sustained delivery formulations of risperidone compounds
granted A61KA61K31/519A61K47/22
Quick answer
US patent 10010612 (Sustained delivery formulations of risperidone compounds) held by Indivior UK Limited expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Indivior UK Limited
- Grant date
- Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/519, A61K47/22, A61K47/32, A61K47/34